Here's Why Oppenheimer Upgraded ImmunoGen To Outperform
February 06, 2015 at 10:45 AM EST
Christopher Marai of Oppenheimer on Thursday upgraded shares of ImmunoGen, Inc. (NASDAQ: IMGN) to Outperform from Perform with an $11 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.